Puberty: Physiology and Abnormalities, 1st ed. 2016

19. Substance Use in Adolescence

Candice E. Van Skike Shannon L. Zandy  and Douglas B. Matthews 

(1)

Department of Pharmaceutical Sciences, University of Kentucky, 789 S. Limestone Street, BioPharm Complex 498, Lexington, KY 40536, USA

(2)

Department of Pharmacy, The University of Texas at Austin, 2409 University Ave, Stop A1915, Austin, TX 78712, USA

(3)

Department of Psychology, University of Wisconsin - Eau Claire, HHH 273, Eau Claire, WI 54701, USA

Candice E. Van Skike

Email: CEVanSkike@gmail.com

Shannon L. Zandy

Email: szandy@utexas.edu

Douglas B. Matthews (Corresponding author)

Email: matthedb@uwec.edu

Keywords

Substance useAdolescenceAdolescentAlcoholNicotineMarijuanaNeurobiology

Introduction

Drug experimentation during adolescence is relatively common [1] and drug use during this time is increased, as the rate of past month illicit drug use in adolescents and young adults is nearly three times that of adults [2]. The initiation and progression of substance use during adolescence is influenced by the distinctive behavioral and neurobiological alterations occurring during this developmental period. Various environmental and psychosocial factors also contribute to the initiation of drug use in adolescents. For instance, personality and psychological factors such as impulsivity, autonomy, depression, and anxiety are all associated with drug use. Additionally, a family history of substance abuse is a contributor to use and dependence [3], but that effect can be mediated by adolescent novelty seeking [4]. This behavior, involving risk taking and sensation seeking, increases during adolescence, which is seen in humans [56] and rodents [7]. This parallels drug intake behavior, with adolescent humans [8] and rodents [911] consuming more of the substances per occasion than adults.

The progression of drug use is driven by drug responses that are unique to this developmental period. For most drugs of abuse , adolescents generally are more sensitive to the rewarding effects of drugs and also experience less aversive consequences than adults [12]. Furthermore, exposure to drugs of abuse during adolescence permanently changes responses to drug use in the future even after a period of abstinence [1316]. Perhaps because of these unique age-dependent effects, there is a clear association between an early age of onset and future substance use disorders [1718]. Therefore, adolescence can be thought of as a period of enhanced vulnerability to substance use and abuse [12].

The adolescent neurobiology is distinct from that of the adult. The adolescent brain is continuing to develop, with brain regions developing at different rates. For instance, activity in the nucleus accumbens, an area important in reward processing, peaks early during adolescence and correlates with increased laboratory risk-taking behavior [19]. The prefrontal cortex , a region that governs cognitive control, develops later than reward-processing regions [20]. It has been speculated that this offset in development of reward and control brain regions underlies the increased risk taking during adolescence, although recent data does not provide support for this theory on an individual basis [20]. Additionally, the molecular targets of drugs of abuse, called receptors, have differential expression patterns and subunit composition that are differentially altered by brain region, age, and drug exposure. The unique neurobiology of the adolescent likely underlies the enhanced vulnerability of the adolescent to substance use and abuse.

With these generalizations in mind , this chapter will review the epidemiology of adolescent drug use, factors contributing to initiation, and the adolescent-specific neurobiological and behavioral consequences of several commonly used drugs during adolescence: nicotine, alcohol, and marijuana. While significant variability exists between all drugs during adolescence, we hope these three serve as hallmark drugs where the reader gains a valuable insight into how drugs impact this developmental window. We consider both human and animal studies to provide a thorough look at the effects of drug use during this time period. Human studies elucidate the epidemiology of drug use and provide data regarding the effects of individual patterns of intake. While reflective of the actual population, the research is limited by the wide variability of intake patterns and polysubstance use. Preclinical research allows for experimental control and manipulation of specific drugs of abuse and patterns of exposure. This permits the study of the behavioral, neurochemical, cellular, and molecular effects of these drugs under specific conditions. We cover both research approaches, as they complement each other when taking a comprehensive look at substance use during adolescence.

Nicotine

Smoking is a leading cause of preventable morbidity and mortality globally and continues to significantly impact public health in the United States. Smoking initiation occurs most often during adolescence and early use of cigarettes is associated with increased risk of dependence later in life [18]. Conventional cigarette smoking is declining overall among American teenagers with 8 % of eighth, tenth and 12th grade students combined reporting smoking in the prior month [1]. However, there has been a substantial rise in popularity of electronic cigarettes (e-cigarettes ) among adolescents. Specifically, the prevalence of e-cigarette use in the last 30 days is more than twice that of regular cigarettes in eighth and tenth grade students and fewer of these students associate significant risks with e-cigarettes compared to conventional cigarettes [1]. This is a concern as e-cigarettes may be a more attractive nicotine delivery method for adolescents. Even low rates of nicotine use during adolescence increases the risk of dependence in adulthood, highlighting the need to understand the factors contributing to early use [21].

There are many environmental and psychosocial factors contributing to smoking initiation in adolescents. Environmental factors, such as exposure to smoking from family members and peers, influence initiation and escalation of smoking in adolescence. For example, parents and the number of friends who smoke is associated with a 30 and 44 % increase in likelihood of adolescent smoking, respectively [22]. Autonomy also plays a significant role in contributing to nicotine use in the adolescent population. As parental involvement declines and decision-making autonomy increases, adolescents are more likely to become smokers, which is shown across ethnic, gender, and socioeconomic groups [23]. In addition, psychological factors such as depression and anxiety are commonly associated with adolescent smoking. Depression and anxiety have been shown to predict initiation of smoking, nicotine dependence, and decreased success at smoking cessation. Young adults that reported elevated depression symptoms as adolescents were found to have significantly higher lifetime smoking rates [24].

Clinical reports suggest an enhanced sensitivity to the positive subjective effects of nicotine may contribute to initiation and continued tobacco use in adolescence. In particular, adult smokers that began smoking during adolescence describe more positive effects and fewer unpleasant side effects of their first smoking episode than smokers that initiated smoking in adulthood [25]. In addition to enhanced positive effects, adolescents may be more resistant to negative effects of nicotine withdrawal, which is a significant predictor of relapse in adult smokers. However, in acute abstinence, adolescent smokers exhibited minimal withdrawal symptoms that were not associated with reports of dependence or biological measures of use [26]. This might indicate that nicotine withdrawal symptoms may not influence maintenance of smoking behavior in adolescents as it does in the adult population. This has important implications for clinical identification and treatment of adolescent nicotine users, as the severity of nicotine withdrawal symptoms is prevalent in current diagnostic criteria and the focus of many available treatment options.

Given that 90 % of adult smokers were under 18 when they had their first cigarette [27], this suggests that there is something unique about the adolescent developmental period that confers increased rates of addiction. Consistent with this notion, preclinical studies indicate that nicotine exposure during the adolescent developmental period perpetuates nicotine use [1013], as well as other drugs of abuse [28]. Specifically, voluntary nicotine intake is higher in adolescent rodents compared to adults [910]. Although nicotine pharmacokinetics is altered in adolescent rats [29], studies suggest the age-dependent intake patterns are based on altered motivational properties of nicotine [10]. Indeed, adolescent rodents are more sensitive than adults to the rewarding effects of nicotine [30]. This increased reward during adolescence persists into adulthood even after a period of abstinence [1315] and corresponds to increased nicotine self-administration later in adulthood compared to adults that were nicotine naïve during adolescence [10]. Furthermore, nicotine exposure during adolescence, but not adulthood, sensitizes future behavioral responses to other drugs of abuse like cocaine [1328], THC [31], and alcohol [32].

The altered short- and long-term consequences of nicotine use during adolescence have a neurobiological basis: the adolescent brain is undergoing maturation [33], so the neurobiological response to nicotine is differentially modulated due to both development and drug exposure. Chronic nicotine exposure alters nicotinic acetylcholine receptor (nAChR) expression in the brain of humans [34] and rodents [35]. Of particular interest due to their ubiquitous expression in mammalian brain [36] and role in nicotine dependence and reinforcement [37] are the α4β2-containing (α4β2*) nAChRs [38]. The α4β2* receptors are differentially expressed throughout the brain based on age and brain region, with an average of 50 % greater radioligand binding to these receptors in adolescent rats [39]. Additionally, adolescents have more α4β2* receptors on dopamine cell bodies and terminal regions than adults [39], and since nicotine-induced dopamine release is mediated by the α4β2* receptors [40], the overexpression of α4β2* receptors in these regions may contribute to the enhancement of the nicotine-induced reward seen during adolescence. Nicotine use upregulates α4β2* and α7 receptors, which are involved in acquisition and dependence [41]. While the upregulation of these receptors is reduced in adolescents versus adults [39], these changes are more persistent and ubiquitous throughout different brain regions in adolescents [42]. This distinct pattern of nAChR expression and nicotine-induced upregulation during adolescence may contribute to the initiation and persistence of nicotine use during adolescence.

Many factors contribute to smoking initiation; however, both human and preclinical research indicates that adolescents have an enhanced sensitivity to nicotine reward. Furthermore, nicotine exposure during adolescence alters future responses to other drugs of abuse, yielding a predisposition toward the development of a substance use disorder.

Ethanol

Alcohol is the most widely used drug by adolescents . Two-thirds of high school students have consumed alcohol by graduation and more than a quarter of students report drinking by eighth grade [1]. Binge drinking (defined as consuming five or more drinks per drinking session for males and four or more per session for females) is the most common drinking pattern among adolescents, often drinking more on average in one session than adults [8]. This is particularly concerning as binge drinking is associated with detrimental effects on brain development and cognition and increased rates of alcohol dependence. The rate of alcohol use dramatically increases between ages 12 and 20, which directly translates into an increase in alcohol use disorders. In fact, the highest prevalence of alcohol dependence occurs in ages 18–20, often referred to as “emerging adulthood,” the period immediately following adolescence [43]. As with other drugs of abuse, age of onset for alcohol use is a significant predictor for future alcohol-related problems. Adolescents that began drinking prior to the age of 14 were shown to have a fourfold greater rate of alcohol dependence than individuals that did not begin drinking until after 20 years old [17].

Aside from rates of alcohol dependence , research has begun to show adolescents with a history of alcohol use differ significantly on cognitive and neural measures compared to those with little or no alcohol use. Studies show alterations in gray and white matter brain structure, poorer neurocognitive performance, and altered brain activation patterns [44]. For example, adolescents with 2 years of heavy drinking history showed abnormalities in brain activation during a spatial working memory task, which was positively correlated to the amount of alcohol use and hangover symptoms reported [45]. There also may be significant gender considerations to be made for consequences of adolescent alcohol use. Females are more vulnerable to alcohol-induced neurotoxicity [4647], an effect that begins to emerge during puberty.

In addition to neurocognitive abnormalities that result from alcohol use, it is also important to highlight neurobiological differences and genetic risks that can increase susceptibility to early initiation of alcohol drinking or heavy patterns of use during adolescence. Poorer performance on tests of inhibitory control in early adolescence prior to any alcohol or drug use was significantly related to heavy alcohol use in later adolescence. Additionally, lower baseline activation and structural differences predict future heavy alcohol use in adolescents [48]. Interestingly, twin studies suggest that environmental influences such as access to alcohol have a large influence on the age that adolescents initiate alcohol use. However, a family history of alcohol misuse has a stronger influence than environmental factors on the amount of alcohol consumed in a session and escalation patterns [49]. Together, these findings suggest that alcohol use in adolescence negatively impacts cognition, brain structure and function, and future health outcomes. Current and future research is leading toward unique opportunities to target prevention and treatment strategies specific to various risk factors within the adolescent population.

Preclinical models also indicate that there is a neurobiological predisposition to excessive binge-like alcohol consumption during adolescence. Indeed, much like adolescent humans [8], adolescent rodents will self-administer greater quantities of alcohol per unit weight than adults [11]. This is likely underscored by age-dependent effects of ethanol on behavior and neurophysiology. Specifically, adolescents are less sensitive to ethanol-induced motor impairments [50], which serve as feedback cues to attenuate consumption within a single drinking session [51]. Changes in cerebellar electrophysiology [50] suggest a neurological correlate for this behavioral difference. Furthermore, adolescents are more sensitive to the ethanol-induced reward and less sensitive to the adverse effects, like acute withdrawal or hangovers [5152]. These altered neurobiological responses create a predisposition toward excessive binge-like alcohol use in the adolescent.

This susceptibility is particularly concerning because adolescents are especially vulnerable to ethanol-induced neurotoxicity, as well as age-specific long-lasting neuroadaptations. For example, after binge alcohol exposure, the adult brain has increased gene expression involved with mechanisms of repair and protection against oxidative damage, while adolescents have decreased expression of these genes and increased proapoptotic gene expression [53]. Some of the ethanol-induced neuroadaptations extend into adulthood and are associated with persistent behavioral changes. For instance, adolescent chronic alcohol exposure yields persistent reductions of hippocampal volume [54], decreased neurogenesis [55], and increased cell death [55]. This is correlated with an increase in disinhibitory behavior [55], suggestive of altered risk-taking behavior. In fact, chronic ethanol exposure increases risk preference in adolescent, but not adult, rats even after nearly 3 weeks of abstinence [56]. Alcohol reward is also altered, as binge-exposed adolescents have reduced dopamine release in adulthood [57]. These neuroadaptations likely underlie alterations in ethanol preference, as rats that were exposed to ethanol during adolescence, but not adulthood, had greater ethanol intake in the future [58], which mirrors the increased rate of future alcohol dependence seen in human adolescents [17]. Overall, preclinical findings mirror the ethanol intake patterns of human adolescents and suggest that alcohol use during adolescence can yield persistent changes in brain and behavior despite long periods of abstinence.

Marijuana

Cannabis is one of the most commonly used illicit drugs among adolescents and adults. The use of marijuana has remained stable the last few years, with over 20 % of 12th grade students reporting use in the previous month [1]. However, attitudes of greater acceptance and less perceived risk are becoming more prevalent among teenagers. In fact, only 36.1 % of high school seniors believe regular use puts them at great risk [1]. While public acceptance increases and legalization of marijuana continues in the United States, it largely remains unclear how cannabis may cause potential alterations in neuromaturational processes during adolescence.

Chronic marijuana use in early adolescence is associated with deficits in cognitive function in humans due to structural changes and decreased connectivity in brain regions important to learning and memory [59]. In fact, short-term memory impairments persist after 6 weeks of abstinence in cannabis-dependent adolescents [60]. Additionally, adolescent marijuana users perform worse on tests of executive functioning, correlating with the number of days of cannabis use in the past 30 days [61]. Although some studies suggest differences in learning and memory can recover to baseline levels following abstinence, attention deficits seem to be persistent [62].

Compelling evidence also suggests adolescent cannabis use is associated with the development of psychosis in adulthood. One prospective study showed an increased risk of psychotic disorders at age 26 associated with cannabis use in adolescence between ages 15–18 [63]. Other studies report early use of cannabis predicts a significant younger age of onset of psychosis and poorer treatment prognoses. Overall, the role of genetics and brain white matter maturation have been hypothesized to contribute to determining whether cannabis use may influence the development of adult psychosis in predisposed individuals.

Functional imaging studies report significant differences in brain activation patterns between adolescent marijuana users and nonusers. Marijuana users show more activation in areas of the brain associated with executive control during an inhibitory processing task, suggesting additional recruitment may be needed to maintain inhibition in adolescents with a history of marijuana use [64]. Additionally, initiation of cannabis use before age 16 is associated with increased brain activation during working memory tasks [65]. A recent longitudinal study found adolescents that reported weekly cannabis use prior to the age of 18 showed greater neuropsychological decline into adulthood, even following prolonged abstinence [66].

The major psychoactive component of cannabis smoke is ∆9-tetrahydrocannabinol (THC) and exerts its effects through agonism of cannabinoid-1 receptors (CB1Rs). Cannabinoid receptors are expressed throughout the brain, increasing during adolescence and are thought to influence gene expression critical for neural development [67]. Therefore, modulation of the endocannabinoid system during adolescence is likely to produce persistent neurological changes. Preclinical studies reveal baseline age-dependent differences in CB1R function that results in differential effects of THC at the CB1Rs. Adolescent CB1Rs are less sensitive to THC-induced desensitization, which corresponds with a lack of tolerance to the memory-impairing effects of THC [68]. Adults also develop tolerance to THC-induced memory impairments, indicating that adolescents may have greater memory impairments due to altered THC-induced neuroadaptations. Indeed, adolescent rats are more sensitive than adults to chronic THC-induced spatial memory impairments , especially at high doses [6970]. These spatial learning deficits in THC-treated adolescents can be attributed to an impaired ability to organize working memory [71] and may arise from THC-suppressing transcription of learning-induced neuroplasticity in the adolescent hippocampus [72].

THC exposure during adolescence has long-term consequences as well. Chronic exposure to THC during adolescence produces residual impairments in spatial working memory, changes in hippocampal morphology, and reduced markers of neuroplasticity that extend into adulthood even after 30 days of abstinence [73]. Additionally, adolescent females appear to be particularly vulnerable to both the short- and long-term consequences of THC exposure, as they are more sensitive to immediate memory disruptions [69] and exhibit depressive symptomology during adulthood [74]. These effects are associated with persistent sex-specific cognitive impairment and neuroplastic alterations of the prefrontal cortex [7576] and are mediated by ovarian hormones [77].

Adolescent THC exposure can also change responsiveness to future illicit drug intake. Subchronic cannabinoid treatment in adolescents and adults suppressed dopamine neuron firing; however, cross-tolerance to cocaine, amphetamine, and morphine was observed for only the adolescent rats exposed to cannabinoids [16]. Furthermore, THC enhances the effects of cocaine in adolescent, but not adult, rats [78]. There is some evidence that THC exposure during adolescence increases responding for heroin in adulthood [79] and subsequently increases heroin relapse rates [80]. This mirrors illicit drug use in surveys of human 'font-size:13.5pt;font-family:"Times New Roman",serif;color:blue'>2].

Together, human and preclinical research suggests marijuana use in adolescence can significantly impact both short- and long-term cognitive performance despite periods of abstinence. Additionally, adolescent marijuana use is associated with altered responses to other drugs of abuse, which likely contribute to the increased rates of illicit drug dependence in adults who began using marijuan a during adolescence [2].

Conclusion

Adolescent drug experimentation is rather common [1], and after reviewing the effects of the three most commonly used drugs during adolescence [81], it is clear that this experimentation is not benign. Drug use during this time period is associated with excessive intake patterns [811], increased rates of future dependence [1718], and altered cognitive outcomes [4459606970] compared to drug use during adulthood. While not all adolescents that experiment with drugs become dependent, adolescence represents a unique time period where the vulnerability to addiction is increased [12]. Adolescent drug use permanently changes future responses to substance use even after a period of abstinence, making drug use more likely to progress [1316283132].

Adolescents have a unique neurobiological composition, partly due to age-related changes in brain structure, function, and neurochemistry. It is likely that because of these innate differences, the effects of drug use during adolescence are different when compared to adulthood. While this has been appreciated in terms of research efforts for several years, it is also necessary to begin to alter therapy and/or treatment options to reflect the inherent differences that exist between adolescents and adults.

Initial onset of drug use during this developmental period is influenced by several factors, including changes in personality, mental health, parental supervision, autonomy, and impulsivity. Maturational changes are rampant during adolescence, with hormonal changes playing a primary role in development. For example, pubertal onset, especially early puberty in males, is associated with increases in substance use [82]. Indeed, the emergence of hormones can produce sex-dependent patterns of intake and escalation of drug use (for an excellent review, see [83]). For instance, unlike the majority of illicit drug use among teens [2], slightly more than half (52 %) of all adolescent prescription drug exposures requiring medical treatment involved females [84]. It is also worthwhile to mention that a significant proportion (38 %) of these prescription drug exposures were suspected suicide attempts [84], perhaps indicative of motivational differences in prescription drug use as compared to other drugs among a specific subset of youth.

Briefly, it is important to consider that other substances like anabolic androgenic steroids (AAS ) may also be used during adolescence and emerging adulthood. Preclinical models of AAS use indicate that AAS administration during adolescence produces increased aggression, whereas no such change is observed in adulthood [85]. In humans, AAS use is associated with impaired attention and impulsivity in both ages, with adolescent-onset users displaying a greater sensitivity to these impairments [86]. Further, AAS use is associated with prescription drug misuse and illicit drug use [87]. This substance is relatively new compared to other drugs of abuse, so population usage data are scarce and its abuse potential has yet to be fully recognized at both the research and clinician levels [88].

Importantly, single substance use is hardly ever found in those who struggle with addiction. The vast majority of the current work, including the much of the current work reviewed here, does not consider the effects of polydrug use. This void of understanding needs to be addressed for research to more accurately address the needs of society.

In conclusion, substance use during adolescence continues to be a societal concern . While decreasing usage rates and further understanding of the neurobiological impact is in progress, additional resources, efforts, and new questions need to be acknowledged to better address the issue. Only through the continued collaboration between research and practitioners will the impact of drug use during adolescence be understood.

References

1.

Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975–2014: overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan; 2015.

2.

Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: summary of national findings, NSDUH series H-48, HHS publication no. (SMA) 14–4863. Rockville: Substance Abuse and Mental Health Services Administration; 2014.

3.

Grant BF. The impact of a family history of alcoholism on the relationship between age at onset of alcohol use and DSM-IV alcohol dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. Alcohol Health Res World. 1998;22(2):144–7.PubMed

4.

Bidwell LC, Knopik VS, Audrain-McGovern J, Glynn TR, Spillane NS, Ray LA, et al. Novelty seeking as a phenotypic marker of adolescent substance use. Subst Abuse. 2015;9 Suppl 1:1–10.PubMedPubMedCentral

5.

Steinberg L, Albert D, Cauffman E, Banich M, Graham S, Woolard J. Age differences in sensation seeking and impulsivity as indexed by behavior and self-report: evidence for a dual systems model. Dev Psychol. 2008;44(6):1764–78.

6.

Crone EA, Bullens L, van der Plas EA, Kijkuit EJ, Zelazo PD. Developmental changes and individual differences in risk and perspective taking in adolescence. Dev Psychopathol. 2008;20(4):1213–29.PubMed

7.

Macrì S, Adriani W, Chiarotti F, Laviola G. Risk taking during exploration of a plus-maze is greater in adolescent than in juvenile or adult mice. Anim Behav. 2002;64(4):541–6.

8.

Masten AS, Faden VB, Zucker RA, Spear LP. A developmental perspective on underage alcohol use. Alcohol Res Health. 2009;32(1):3–15.PubMedPubMedCentral

9.

Levin ED, Slade S, Wells C, Cauley M, Petro A, Vendittelli A, et al. Threshold of adulthood for the onset of nicotine self-administration in male and female rats. Behav Brain Res. 2011;225(2):473–81.PubMedPubMedCentral

10.

Natividad LA, Torres OV, Friedman TC, O’Dell LE. Adolescence is a period of development characterized by short- and long-term vulnerability to the rewarding effects of nicotine and reduced sensitivity to the anorectic effects of this drug. Behav Brain Res. 2013;257:275–85.PubMedPubMedCentral

11.

Doremus TL, Brunell SC, Rajendran P, Spear LP. Factors influencing elevated ethanol consumption in adolescent relative to adult rats. Alcohol Clin Exp Res. 2005;29(10):1796–808.PubMed

12.

Schramm-Sapyta NL, Walker QD, Caster JM, Levin ED, Kuhn CM. Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models. Psychopharmacology (Berl). 2009;206(1):1–21.

13.

Adriani W, Deroche-Gamonet V, Le Moal M, Laviola G, Piazza PV. Preexposure during or following adolescence differently affects nicotine-rewarding properties in adult rats. Psychopharmacology (Berl). 2006;184(3–4):382–90.

14.

de la Peña JB, Ahsan HM, Botanas CJ, Sohn A, Yu GY, Cheong JH. Adolescent nicotine or cigarette smoke exposure changes subsequent response to nicotine conditioned place preference and self-administration. Behav Brain Res. 2014;272:156–64.PubMed

15.

de la Peña JB, Ahsan HM, Tampus R, Botanas CJ, dela Peña IJ, Kim HJ, et al. Cigarette smoke exposure during adolescence enhances sensitivity to the rewarding effects of nicotine in adulthood, even after a long period of abstinence. Neuropharmacology. 2015;99:9–14.PubMed

16.

Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiatry. 2004;56(2):86–94.PubMed

17.

Grant BF, Dawson DA. Age at onset of alcohol use and its association with DSM-IV alcohol abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse. 1997;9:103–10.PubMed

18.

Chen K, Kandel DB. The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am J Public Health. 1995;85(1):41–7.PubMedPubMedCentral

19.

Braams BR, van Duijvenvoorde AC, Peper JS. Longitudinal changes in adolescent risk-taking: a comprehensive study of neural responses to rewards, pubertal development, and risk-taking behavior. J Neurosci. 2015;35(18):7226–38.PubMed

20.

Mills KL, Goddings AL, Clasen LS, Giedd JN, Blakemore SJ. The developmental mismatch in structural brain maturation during adolescence. Dev Neurosci. 2014;36(3–4):147–60.PubMed

21.

Riggs NR, Chou CP, Li C, Pentz MA. Adolescent to emerging adulthood smoking trajectories: when do smoking trajectories diverge, and do they predict early adulthood nicotine dependence? Nicotine Tob Res. 2007;9(11):1147–54.PubMed

22.

Wang MQ, Fitzhugh EC, Green BL, Turner LW, Eddy JM, Westerfield RC. Prospective social-psychological factors of adolescent smoking progression. J Adolesc Health. 1999;24(1):2–9.PubMed

23.

Radziszewska B, Richardson JL, Dent CW, Flay BR. Parenting style and adolescent depressive symptoms, smoking, and academic achievement: ethnic, gender, and SES differences. J Behav Med. 1996;19(3):289–305.PubMed

24.

Kandel DB, Davies M. Adult sequelae of adolescent depressive symptoms. Arch Gen Psychiatry. 1986;43(3):255–62.PubMed

25.

Eissenberg T, Balster RL. Initial tobacco use episodes in children and adolescents: current knowledge, future directions. Drug Alcohol Depend. 2000;59 Suppl 1:S41–60.PubMed

26.

Smith AE, Cavallo DA, Dahl T, Wu R, George TP, Krishnan-Sarin S. Effects of acute tobacco abstinence in adolescent smokers compared with nonsmokers. J Adolesc Health. 2008;43(1):46–54.PubMedPubMedCentral

27.

US Department of Health and Human Services. Preventing tobacco use among youth and young adults: a report of the Surgeon General. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2012.

28.

McQuown SC, Belluzzi JD, Leslie FM. Low dose nicotine treatment during early adolescence increases subsequent cocaine reward. Neurotoxicol Teratol. 2007;29(1):66–73.PubMed

29.

Craig EL, Zhao B, Cui JZ, Novalen M, Miksys S, Tyndale RF. Nicotine pharmacokinetics in rats is altered as a function of age, impacting the interpretation of animal model data. Drug Metab Dispos. 2014;42(9):1447–55.PubMedPubMedCentral

30.

Belluzzi JD, Lee AG, Oliff HS, Leslie FM. Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl). 2004;174(3):389–95.

31.

Werling LL, Reed SC, Wade D, Izenwasser S. Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats. Int J Dev Neurosci. 2009;27(3):263–9.PubMedPubMedCentral

32.

Burns BE, Proctor WR. Cigarette smoke exposure greatly increases alcohol consumption in adolescent C57BL/6 mice. Alcohol Clin Exp Res. 2013;37 Suppl 1:E364–72.PubMed

33.

Lydon DM, Wilson SJ, Child A, Geier CF. Adolescent brain maturation and smoking: what we know and where we’re headed. Neurosci Biobehav Rev. 2014;45:323–42.PubMedPubMedCentral

34.

Jasinska AJ, Zorick T, Brody AL, Stein EA. Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans. Neuropharmacology. 2014;84:111–22.PubMed

35.

Baker LK, Mao D, Chi H, Govind AP, Vallejo YF, Iacoviello M, et al. Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug. Eur J Neurosci. 2013;37(6):1004–11.PubMedPubMedCentral

36.

Wu J, Liu Q, Yu K, Hu J, Kuo YP, Segerberg M, et al. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors. J Physiol. 2006;576(Pt 1):103–18.PubMedPubMedCentral

37.

Walters CL, Brown S, Changeux JP, Martin B, Damaj MI. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl). 2006;184(3–4):339–44.

38.

McKee SA, Weinberger AH. How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use? Annu Rev Clin Psychol. 2013;9:649–74.PubMed

39.

Doura MB, Gold AB, Keller AB, Perry DC. Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure. Brain Res. 2008;1215:40–52.PubMedPubMedCentral

40.

Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C, et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci. 2003;23(21):7820–9.PubMed

41.

Stoker AK, Markou A. Unraveling the neurobiology of nicotine dependence using genetically engineered mice. Curr Opin Neurobiol. 2013;23(4):493–9.PubMedPubMedCentral

42.

Trauth JA, Seidler FJ, McCook EC, Slotkin TA. Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res. 1999;851(1–2):9–19.PubMed

43.

Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend. 2004;74(3):223–34.PubMed

44.

Jacobus J, Tapert SF. Neurotoxic effects of alcohol in adolescence. Annu Rev Clin Psychol. 2013;9:703–21.PubMed

45.

Tapert SF, Schweinsburg AD, Barlett VC, Brown SA, Frank LR, Brown GG, et al. Blood oxygen level dependent response and spatial working memory in adolescents with alcohol use disorders. Alcohol Clin Exp Res. 2004;28(10):1577–86.PubMed

46.

Hommer D, Momenan R, Kaiser E, Rawlings R. Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry. 2001;158(2):198–204.PubMed

47.

Pfefferbaum A, Rosenbloom M, Deshmukh A, Sullivan E. Sex differences in the effects of alcohol on brain structure. Am J Psychiatry. 2001;158(2):188–97.PubMed

48.

Squeglia LM, Boissoneault J, Van Skike CE, Nixon SJ, Matthews DB. Age-related effects of alcohol from adolescent, adult, and aged populations using human and animal models. Alcohol Clin Exp Res. 2014;38(10):2509–16.PubMedPubMedCentral

49.

Spear LP. Adolescent alcohol exposure: are there separable vulnerable periods within adolescence? Physiol Behav. 2015;148:122–30.PubMed

50.

Van Skike CE, Botta P, Chin VS, Tokunaga S, McDaniel JM, Venard J, et al. Behavioral effects of ethanol in cerebellum are age dependent: potential system and molecular mechanisms. Alcohol Clin Exp Res. 2010;34(12):2070–80.PubMedPubMedCentral

51.

Spear LP, Varlinskaya EI. Adolescence. Alcohol sensitivity, tolerance, and intake. Recent Dev Alcohol. 2005;17:143–59.PubMed

52.

Ehlers CL, Desikan A, Wills DN. Developmental differences in EEG and sleep responses to acute ethanol administration and its withdrawal (hangover) in adolescent and adult Wistar rats. Alcohol. 2013;47(8):601–10.PubMedPubMedCentral

53.

Lacaille H, Duterte-Boucher D, Liot D, Vaudry H, Naassila M, Vaudry D. Comparison of the deleterious effects of binge drinking-like alcohol exposure in adolescent and adult mice. J Neurochem. 2015;132(6):629–41.PubMed

54.

Ehlers CL, Oguz I, Budin F, Wills DN, Crews FT. Peri-adolescent ethanol vapor exposure produces reductions in hippocampal volume that are correlated with deficits in prepulse inhibition of the startle. Alcohol Clin Exp Res. 2013;37(9):1466–75.PubMedPubMedCentral

55.

Ehlers CL, Liu W, Wills DN, Crews FT. Periadolescent ethanol vapor exposure persistently reduces measures of hippocampal neurogenesis that are associated with behavioral outcomes in adulthood. Neuroscience. 2013;244:1–15.PubMedPubMedCentral

56.

Schindler AG, Tsutsui KT, Clark JJ. Chronic alcohol intake during adolescence, but not adulthood, promotes persistent deficits in risk-based decision making. Alcohol Clin Exp Res. 2014;38(6):1622–9.PubMedPubMedCentral

57.

Zandy SL, Matthews DB, Tokunaga S, Miller AD, Blaha CD, Mittleman G. Reduced dopamine release in the nucleus accumbens core of adult rats following adolescent binge alcohol exposure: age and dose-dependent analysis. Psychopharmacology (Berl). 2015;232(4):777–84.

58.

Fabio MC, Nizhnikov ME, Spear NE, Pautassi RM. Binge ethanol intoxication heightens subsequent ethanol intake in adolescent, but not adult, rats. Dev Psychobiol. 2014;56(3):574–83.PubMed

59.

Renard J, Krebs MO, Le Pen G, Jay TM. Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. Front Neurosci. 2014;8:361.PubMedPubMedCentral

60.

Schwartz RH, Gruenewald PJ, Klitzner M, Fedio P. Short-term memory impairment in cannabis-dependent adolescents. Am J Dis Child. 1989;143(10):1214–9.PubMed

61.

Harvey MA, Sellman JD, Porter RJ, Frampton CM. The relationship between non-acute adolescent cannabis use and cognition. Drug Alcohol Rev. 2007;26(3):309–19.PubMed

62.

Hanson KL, Winward JL, Schweinsburg AD, Medina KL, Brown SA, Tapert SF. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addict Behav. 2010;35(11):970–6.PubMedPubMedCentral

63.

Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325(7374): 1212–3.PubMedPubMedCentral

64.

Tapert SF, Schweinsburg AD, Drummond SP, Paulus MP, Brown SA, Yang TT, et al. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (Berl). 2007;194(2):173–83.

65.

Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J. The impact of early-onset cannabis use on functional brain correlates of working memory. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(6):837–45.PubMed

66.

Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109(40):E2657–64.PubMedPubMedCentral

67.

Rubino T, Parolaro D. Long lasting consequences of cannabis exposure in adolescence. Mol Cell Endocrinol. 2008;286(1–2 Suppl 1):S108–13.PubMed

68.

Moore NL, Greenleaf AL, Acheson SK, Wilson WA, Swartzwelder HS, Kuhn CM. Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats. J Pharmacol Exp Ther. 2010;335(2):294–301.PubMedPubMedCentral

69.

Cha YM, Jones KH, Kuhn CM, Wilson WA, Swartzwelder HS. Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats. Behav Pharmacol. 2007;18(5–6):563–9.PubMed

70.

Cha YM, White AM, Kuhn CM, Wilson WA, Swartzwelder HS. Differential effects of delta9-THC on learning in adolescent and adult rats. Pharmacol Biochem Behav. 2006;83(3):448–55.PubMed

71.

Steel RW, Miller JH, Sim DA, Day DJ. Learning impairment by ∆(9)-tetrahydrocannabinol in adolescence is attributable to deficits in chunking. Behav Pharmacol. 2011;22(8):837–46.PubMed

72.

Steel RW, Miller JH, Sim DA, Day DJ. Delta-9-tetrahydrocannabinol disrupts hippocampal neuroplasticity and neurogenesis in trained, but not untrained adolescent Sprague–Dawley rats. Brain Res. 2014;1548:12–9.PubMed

73.

Rubino T, Realini N, Braida D, Guidi S, Capurro V, Vigano D, et al. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus. 2009;19(8):763–72.PubMed

74.

Rubino T, Vigano D, Realini N, Guidali C, Braida D, Capurro V, et al. Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology. 2008;33(11):2760–71.PubMed

75.

Rubino T, Prini P, Piscitelli F, Zamberletti E, Trusel M, Melis M, et al. Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiol Dis. 2015;73:60–9.PubMed

76.

Rubino T, Realini N, Braida D, Alberio T, Capurro V, Vigano D, et al. The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex. Neurotox Res. 2009;15(4):291–302.PubMed

77.

Winsauer PJ, Daniel JM, Filipeanu CM, Leonard ST, Hulst JL, Rodgers SP, et al. Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status. Addict Biol. 2011;16(1):64–81.PubMedPubMedCentral

78.

Dow-Edwards D, Izenwasser S. Pretreatment with ∆9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats. Pharmacol Biochem Behav. 2012;100(3):587–91.PubMed

79.

Ellgren M, Spano SM, Hurd YL. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology. 2007;32(3):607–15.PubMed

80.

Stopponi S, Soverchia L, Ubaldi M, Cippitelli A, Serpelloni G, Ciccocioppo R. Chronic THC during adolescence increases the vulnerability to stress-induced relapse to heroin seeking in adult rats. Eur Neuropsychopharmacol. 2014;24(7):1037–45.PubMed

81.

Johnston LD, Miech RA, O’Malley PM, Bachman JG, Schulenberg JE. Use of alcohol, cigarettes, and number of illicit drugs declines among U.S. teens. Ann Arbor: University of Michigan News Service; 2014. http://www.monitoringthefuture.org. Retrieved 03 Aug 2015.

82.

Kaltiala-Heino R, Koivisto AM, Marttunen M, Frojd S. Pubertal timing and substance use in middle adolescence: a 2-year follow-up study. J Youth Adolesc. 2011;40:1288–301.PubMed

83.

Kuhn C. Emergence of sex differences in the development of substance use and abuse during adolescence. Pharmacol Ther. 2015;153:55–78.PubMed

84.

Zosel A, Bartelson BB, Bailey E, Lowenstein S, Dart R. Characterization of adolescent prescription drug abuse and misuse using the Research Abuse Diversion and Addiction-related Surveillance (RADARS(®)) System. J Am Acad Child Adolesc Psychiatry. 2013;52:196–204.e2.PubMedPubMedCentral

85.

Morrison TR, Ricci LA, Melloni Jr RH. Anabolic/androgenic steroid administration during adolescence and adulthood differentially modulates aggression and anxiety. Horm Behav. 2015;69:132–8.PubMedPubMedCentral

86.

Hildebrandt T, Langenbucher JW, Flores A, Harty S, Berlin HA. The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men. Psychol Addict Behav. 2014;28:1096–104.PubMedPubMedCentral

87.

Hakansson A, Mickelsson K, Wallin C, Berglund M. Anabolic androgenic steroids in the general population: user characteristics and associations with substance use. Eur Addict Res. 2012;18:83–90.PubMed

88.

Pope Jr HG, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014;23:371–7.PubMed


Previous
Page
Next
Page